2BBBullish & Bearish
Brainsway Ltd. (BWAY) trades on NASDAQ. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 35 out of 100.
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives.
Brainsway Ltd.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 18 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 68 | Strong |
| Quality | 100 | Very Strong |
| Risk | 29 | Low (provisional) |
| CEO | Hadar Levy | Christopher von Jako |
| Headquarters | Jerusalem, Jerusalem District, Israel |
| Founded | 2003 |
| Employees | 129 |
| P/E ratio | 47.80 |
| 52-week range | $7.14 – $17.40 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-09 | — | 0.2221 | — | $56.22M |
| 2026-11-10 | — | 0.213 | — | $53.76M |